This week, we talk to Kevin O'Brien, President, North America, Merz Therapeutics, about the intricacies of developing a treatment for a new indication, translating a company culture online, and leadership lessons he has learnt because of COVID-19. Please note the product discussed in this podcast has a black box warning and could result in potentially serious side effects.
